Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemagglutinase vs Adrenalin vs Tranexamic Acid for Iatrogenic Endobronchial Bleeding
NCT06149091Phase 1Unknown
- Sponsor
- China-Japan Friendship Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of batroxobin in hemoptysis (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Intratracheal bleeding control rate at 1 minute. Status: unknown.
02
Drugs
batroxobin
03
Conditions
hemoptysis
Beyond the preview
Go deeper on NCT06149091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06149091.